Morgan Stanley’s Adamas Pharmaceuticals, Inc. ADMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q4
Sell
-67,118
Closed -$329K 8390
2021
Q3
$329K Sell
67,118
-6,115
-8% -$30K ﹤0.01% 5733
2021
Q2
$387K Sell
73,233
-265,481
-78% -$1.4M ﹤0.01% 5685
2021
Q1
$1.63M Sell
338,714
-768,511
-69% -$3.69M ﹤0.01% 4419
2020
Q4
$4.79M Buy
1,107,225
+807,951
+270% +$3.5M ﹤0.01% 3300
2020
Q3
$1.23M Sell
299,274
-48,876
-14% -$201K ﹤0.01% 4059
2020
Q2
$892K Sell
348,150
-166,947
-32% -$428K ﹤0.01% 4258
2020
Q1
$1.49M Buy
515,097
+482,376
+1,474% +$1.39M ﹤0.01% 3622
2019
Q4
$124K Buy
32,721
+19,040
+139% +$72.2K ﹤0.01% 5582
2019
Q3
$70K Buy
13,681
+12,182
+813% +$62.3K ﹤0.01% 5577
2019
Q2
$10K Sell
1,499
-6,598
-81% -$44K ﹤0.01% 6146
2019
Q1
$58K Sell
8,097
-546,172
-99% -$3.91M ﹤0.01% 5609
2018
Q4
$4.73M Buy
554,269
+506,081
+1,050% +$4.32M ﹤0.01% 2974
2018
Q3
$965K Sell
48,188
-23,097
-32% -$463K ﹤0.01% 4569
2018
Q2
$1.84M Buy
71,285
+5,045
+8% +$130K ﹤0.01% 4151
2018
Q1
$1.58M Sell
66,240
-137,776
-68% -$3.29M ﹤0.01% 4210
2017
Q4
$6.92M Buy
204,016
+173,230
+563% +$5.87M ﹤0.01% 2741
2017
Q3
$652K Buy
30,786
+3,746
+14% +$79.3K ﹤0.01% 4711
2017
Q2
$472K Sell
27,040
-3,308
-11% -$57.7K ﹤0.01% 4837
2017
Q1
$531K Sell
30,348
-25,580
-46% -$448K ﹤0.01% 4798
2016
Q4
$944K Buy
55,928
+44,398
+385% +$749K ﹤0.01% 4509
2016
Q3
$189K Buy
11,530
+9,789
+562% +$160K ﹤0.01% 5046
2016
Q2
$26K Sell
1,741
-4,159
-70% -$62.1K ﹤0.01% 5765
2016
Q1
$85K Sell
5,900
-2,407
-29% -$34.7K ﹤0.01% 5387
2015
Q4
$235K Sell
8,307
-190
-2% -$5.38K ﹤0.01% 5000
2015
Q3
$142K Sell
8,497
-3,474
-29% -$58.1K ﹤0.01% 5256
2015
Q2
$314K Sell
11,971
-3,007
-20% -$78.9K ﹤0.01% 4993
2015
Q1
$262K Sell
14,978
-10,647
-42% -$186K ﹤0.01% 5063
2014
Q4
$445K Buy
25,625
+25,224
+6,290% +$438K ﹤0.01% 4745
2014
Q3
$7K Sell
401
-10,110
-96% -$176K ﹤0.01% 6277
2014
Q2
$192K Buy
+10,511
New +$192K ﹤0.01% 5179